Citicoline injections improve movement for people with Parkinson's

Researchers in Italy tested whether a natural brain compound called citicoline could give an extra boost to everyday Parkinson's medications. In the body, citicoline acts as a natural building block for brain cells, helping to repair cell walls and support dopamine, the chemical messenger that helps control movement. The study, called the CITIPARK trial, followed 474 people who were already taking their regular medicines. One group received a daily injection of citicoline in two six week rounds, while the other group received an inactive dummy injection called a placebo. Neither the participants nor their doctors knew who was receiving the real compound, ensuring fair and accurate results. By the end of the twenty four week study, people receiving citicoline saw clear physical gains. Their movement scores improved significantly more than those in the dummy group, making everyday motions smoother and easier to manage. In fact, more than half of the people given citicoline had improvements big enough to make a genuine, noticeable difference in their daily lives. Citicoline also proved to be very gentle and safe, with participants reporting no troublesome side effects compared to the placebo. While future research will test whether simple daily tablets can match the benefits of the injections used in this trial, these results show that citicoline is a safe and promising ally alongside standard treatments. This was a late stage, phase three randomised controlled trial designed to confirm therapeutic efficacy and safety across a large group of people in multiple specialist centres. While citicoline is already widely sold over the counter in many countries as a dietary supplement or nootropic tablet, this trial tested a high dose prescription grade injection. Before doctors can routinely prescribe it as an official medical treatment for Parkinson’s, regulatory bodies require further confirmatory studies, especially trials testing whether convenient daily oral tablets or syrups match the benefits of the injections used here. Anyone considering taking dietary forms should always consult their neurologist first to check suitability alongside their current regimen.